featured
Molecular Subtypes and APOBEC3G Predict Response to Adjuvant Chemotherapy in Urothelial Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
Cancer Med 2022 Oct 07;[EPub Ahead of Print], C Olah, H Reis, MJ Hoffmann, F Mairinger, S Ting, B Hadaschik, U Krafft, V Grünwald, P Nyirady, M Varadi, B Győrffy, A Kiss, E Szekely, G Sjödahl, T SzarvasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.